Non-Credit - Adjunct Instructor: Radioligand Therapy; RLT) Manufacturing & Operations Training
Listed on 2026-10-05
-
Education / Teaching
Medical Education
Location: Indianapolis
Job Title:
Non-Credit Adjunct Instructor:
Radioligand Therapy (RLT) Manufacturing & Operations Training
Location:
Indianapolis
Job Type: Contracted Technical Training, Adjunct Instructor
Classification:
Skills Training Adjunct Faculty
Salary Range:
Salary varies
- Based on qualifications and experience
Reports To:
Ivy+ Career Link Project Manager
Ivy Tech is Indiana’s community college and workforce engine, delivering: high-quality learning experiences that propel Indiana’s communities, measurable economic return, excellence in teaching, and industry-aligned credentials of value, empowering every learner to achieve lifelong success
Our Values:- Empathy
- We lead with care and connectivity, ensuring we meet our students where they are. - Integrity
- We act responsibly and ethically in the best interest of our students, employees, partners, institution, and the State. - Agility
- We move with purpose and adapt to the evolving needs of our students, employers, and the State. - Impact
- We exist to change lives through quality education.
About The Role:
The adjunct specialist for Radioligand Therapy is responsible for delivering a structured 32-hour foundational training program for incumbent employees and new operators entering radioligand therapy manufacturing operations. This role ensures learners achieve operator‑level competency in radiopharmaceutical production, aseptic processing, radiation safety, and current Good Manufacturing Practice (cGMP) requirements. The instructor will translate complex radiochemistry, sterile manufacturing principles, and regulatory expectations into applied, hands‑on learning experiences that prepare employees to safely and effectively operate within a radioligand therapy production environment.
Instructional materials and course content are developed by Ivy Tech subject matter experts. The instructor is responsible for facilitating learning, connecting concepts to industry practice, guiding hands‑on activities, and assessing learner competency.
Training Program Ownership (Core Responsibility):
The instructor will lead delivery of a Radioligand Therapy Operator Training Program that combines lecture, discussion, and guided hands‑on activities to develop workforce readiness in radiopharmaceutical manufacturing. Instruction is delivered through scheduled 3–5‑day bootcamp cohorts as a part‑time adjunct teaching assignment.
Course:
Non‑Credit Radioligand Therapy Operator Training:
The Radioligand Therapy course is a foundational program introducing operators to radioligands and cancer therapy drug manufacturing operations. The course builds operator‑level competencies across radiopharmaceutical production, aseptic processing, and quality systems. Learners are trained in radioactive isotopes, decay physics, lutetium‑177 chemistry, ligand systems, and end‑to‑end manufacturing processes including aseptic filling, sterile filtration, and quality control testing. Through this bootcamp‑style instruction, participants develop the knowledge and skills required for work in a regulated biopharmaceutical manufacturing environment.
Candidates are not expected to be subject matter experts in every topic listed below. Instructors should possess relevant industry experience and working knowledge across many of the following areas.
Relevant Areas:- Radiochemistry & Core Science
- Radioactive isotopes
- Radioactive decay and half‑life
- Lutetium‑177 chemistry
- Ligand systems and radiolabeling principles
- Radioactivity handling and decay calculations
- Radiopharmaceutical Manufacturing Process
- End‑to‑end manufacturing workflow overview
- Radiolabeling of precursor with ¹⁷⁷LuCl₃
- Production solution preparation
- Formulation processes
- Aseptic filling operations
- Line clearance procedures
- Final drug product handling
- Aseptic…
(If this job is in fact in your jurisdiction, then you may be using a Proxy or VPN to access this site, and to progress further, you should change your connectivity to another mobile device or PC).